Cavan John T 4
4 · ContraVir Pharmaceuticals, Inc. · Filed Jan 5, 2018
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Award
Common Stock
2018-01-03+101,221→ 167,947 total
Footnotes (1)
- [F1]The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.